Research
Area 3
Liver transplantation and graft viability
Team leader
Antoni Rimola
(Hospital Clínic)
ARIMOLA(ELIMINAR)@clinic.ub.es
Strategic objectives
Investigation of clinical, mechanistic and therapeutic aspects of liver transplantation.
Main lines of research
1. Ischemia-reperfusion liver damage in different models: warm ischemia; experimental liver transplantation in the rat with normal reduced or steatosic grafts; experimental liver transplantation in the pig with whole or partial grafts, or grafts obtained from donors in asystolia; and liver transplantation in humans.
2. Immune suppression, with special interest in three fields: immune tolerance of the allograft, biomarkers of the effects of immune suppressors, and identification of populations with different risks of rejection.